Skip to content

Revance Therapeutics, Inc.

Delisted

CIK 1479290fmd_0X1RRQ7H8N7F9GZE3D44E3HETDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2002 to Sep 30, 2024, 58 periods

Proof

Every number on this company page links to a proof: the filing it came from, the XBRL tag, the knowledge interval, and the raw facts it was built from. Hover any cell in Financials for the summary; click to open the full record.

How to read a proof

  1. Accession and form identify the filing; the SEC link opens the primary document.
  2. Tag, dimensions and decimals identify the fact within that filing.
  3. The knowledge interval says when this value became known and, if restated, when it stopped being current.
  4. Derived values list every as-reported fact in the chain.
Open Financials
FinancialMD terminal